860 related articles for article (PubMed ID: 32961257)
1. Oncometabolites lactate and succinate drive pro-angiogenic macrophage response in tumors.
Kes MMG; Van den Bossche J; Griffioen AW; Huijbers EJM
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188427. PubMed ID: 32961257
[TBL] [Abstract][Full Text] [Related]
2. Unveiling the veil of lactate in tumor-associated macrophages: a successful strategy for immunometabolic therapy.
Tao H; Zhong X; Zeng A; Song L
Front Immunol; 2023; 14():1208870. PubMed ID: 37564659
[TBL] [Abstract][Full Text] [Related]
3. The role of glycolysis and lactate in the induction of tumor-associated macrophages immunosuppressive phenotype.
Zhang Y; Zhang X; Meng Y; Xu X; Zuo D
Int Immunopharmacol; 2022 Sep; 110():108994. PubMed ID: 35777265
[TBL] [Abstract][Full Text] [Related]
4. Targeting tumor-associated macrophages as an antitumor strategy.
Cheng N; Bai X; Shu Y; Ahmad O; Shen P
Biochem Pharmacol; 2021 Jan; 183():114354. PubMed ID: 33279498
[TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
6. Macrophage Metabolism Controls Tumor Blood Vessel Morphogenesis and Metastasis.
Wenes M; Shang M; Di Matteo M; Goveia J; Martín-Pérez R; Serneels J; Prenen H; Ghesquière B; Carmeliet P; Mazzone M
Cell Metab; 2016 Nov; 24(5):701-715. PubMed ID: 27773694
[TBL] [Abstract][Full Text] [Related]
7. Fasting mimicking diet inhibits tumor-associated macrophage survival and pro-tumor function in hypoxia: implications for combination therapy with anti-angiogenic agent.
Wang L; Wang YJ; Wang R; Gong FL; Shi YH; Li SN; Chen PP; Yuan YF
J Transl Med; 2023 Oct; 21(1):754. PubMed ID: 37884960
[TBL] [Abstract][Full Text] [Related]
8. The Role of Tumor Associated Macrophages (TAMs) in Cancer Progression, Chemoresistance, Angiogenesis and Metastasis - Current Status.
Dallavalasa S; Beeraka NM; Basavaraju CG; Tulimilli SV; Sadhu SP; Rajesh K; Aliev G; Madhunapantula SV
Curr Med Chem; 2021; 28(39):8203-8236. PubMed ID: 34303328
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy of simvastatin and 5, 6-dimethylxanthenone-4-acetic acid synergistically suppresses the aggressiveness of B16.F10 melanoma cells.
Rauca VF; Licarete E; Luput L; Sesarman A; Patras L; Bulzu P; Rakosy-Tican E; Banciu M
PLoS One; 2018; 13(8):e0202827. PubMed ID: 30138430
[TBL] [Abstract][Full Text] [Related]
10. Targeting tumor-associated macrophages for cancer immunotherapy.
Shu Y; Cheng P
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188434. PubMed ID: 32956767
[TBL] [Abstract][Full Text] [Related]
11. Targeting tumor-associated macrophages: A potential treatment for solid tumors.
Chen Y; Jin H; Song Y; Huang T; Cao J; Tang Q; Zou Z
J Cell Physiol; 2021 May; 236(5):3445-3465. PubMed ID: 33200401
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy.
Zhang SY; Song XY; Li Y; Ye LL; Zhou Q; Yang WB
Pharmacol Res; 2020 Nov; 161():105111. PubMed ID: 33065284
[TBL] [Abstract][Full Text] [Related]
13. Macrophages are metabolically heterogeneous within the tumor microenvironment.
Geeraerts X; Fernández-Garcia J; Hartmann FJ; de Goede KE; Martens L; Elkrim Y; Debraekeleer A; Stijlemans B; Vandekeere A; Rinaldi G; De Rycke R; Planque M; Broekaert D; Meinster E; Clappaert E; Bardet P; Murgaski A; Gysemans C; Nana FA; Saeys Y; Bendall SC; Laoui D; Van den Bossche J; Fendt SM; Van Ginderachter JA
Cell Rep; 2021 Dec; 37(13):110171. PubMed ID: 34965415
[TBL] [Abstract][Full Text] [Related]
14. Arginase-1+ Exosomes from Reprogrammed Macrophages Promote Glioblastoma Progression.
Azambuja JH; Ludwig N; Yerneni SS; Braganhol E; Whiteside TL
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32498400
[TBL] [Abstract][Full Text] [Related]
15. The roles of tumor-associated macrophages in tumor angiogenesis and metastasis.
Fu LQ; Du WL; Cai MH; Yao JY; Zhao YY; Mou XZ
Cell Immunol; 2020 Jul; 353():104119. PubMed ID: 32446032
[TBL] [Abstract][Full Text] [Related]
16. The role of tumor-associated macrophage in breast cancer biology.
Choi J; Gyamfi J; Jang H; Koo JS
Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
[TBL] [Abstract][Full Text] [Related]
17. Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment.
Deryugina EI; Zajac E; Juncker-Jensen A; Kupriyanova TA; Welter L; Quigley JP
Neoplasia; 2014 Oct; 16(10):771-88. PubMed ID: 25379015
[TBL] [Abstract][Full Text] [Related]
18. BRD4 Inhibition by AZD5153 Promotes Antitumor Immunity via Depolarizing M2 Macrophages.
Li X; Fu Y; Yang B; Guo E; Wu Y; Huang J; Zhang X; Xiao R; Li K; Wang B; Hu J; Sun C; Chen G
Front Immunol; 2020; 11():89. PubMed ID: 32184777
[TBL] [Abstract][Full Text] [Related]
19. B7-H3 augments the pro-angiogenic function of tumor-associated macrophages and acts as a novel adjuvant target for triple-negative breast cancer therapy.
Cheng N; Bei Y; Song Y; Zhang W; Xu L; Zhang W; Yang N; Bai X; Shu Y; Shen P
Biochem Pharmacol; 2021 Jan; 183():114298. PubMed ID: 33153969
[TBL] [Abstract][Full Text] [Related]
20. The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target.
Gambardella V; Castillo J; Tarazona N; Gimeno-Valiente F; Martínez-Ciarpaglini C; Cabeza-Segura M; Roselló S; Roda D; Huerta M; Cervantes A; Fleitas T
Cancer Treat Rev; 2020 Jun; 86():102015. PubMed ID: 32248000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]